SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
62 hedge funds and large institutions have $223M invested in scPharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
25% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 12
5.87% more ownership
Funds ownership: 62.88% → 68.75% (+5.9%)
5% more funds holding
Funds holding: 59 → 62 (+3)
Holders
62
Holding in Top 10
4
Calls
$990K
Puts
$591K
Top Buyers
| 1 | +$29.9M | |
| 2 | +$25.5M | |
| 3 | +$11.9M | |
| 4 |
Morgan Stanley
New York
|
+$9.24M |
| 5 |
Millennium Management
New York
|
+$7.51M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$13.9M | |
| 3 | -$13.3M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$6.83M |
| 5 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$4.3M |